Common use of BOARD’S APPROVAL Clause in Contracts

BOARD’S APPROVAL. The BACT Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps, were approved by the Board. As at the date of this announcement, there are no overlapping directors and senior management between the Company and BACT. Moreover, while the executive Directors and the non-executive Directors concurrently serve as director or senior management of the Parent Company, none of the Directors personally has any material interest in the transactions contemplated under the BACT Premises Leasing Agreement entered into by the Company and BACT. Therefore, none of the Directors has abstained from voting at the Board meeting to approve the BACT Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps. LISTING RULES IMPLICATIONS As at the date of this announcement, the Parent Company is the controlling shareholder of the Company, holding approximately 58.96% of the issued share capital of the Company. BACT is a wholly-owned subsidiary of the Parent Company and is therefore a connected person of the Company. Accordingly, the BACT Premises Leasing Agreement and the transactions contemplated thereunder constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules. As the highest applicable percentage ratio (as defined under Rule 14.07 of the Listing Rules) in respect of the BACT Premises Leasing Agreement is more than 0.1% but less than 5%, the BACT Premises Leasing Agreement and the transactions contemplated thereunder are subject to the reporting, annual review and announcement requirements, but exempt from the Independent Shareholders’ approval requirement under Chapter 14A of the Listing Rules.

BOARD’S APPROVAL. The BACT Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps, Business Jet Ground Services Joint Operation Agreements were approved by the Board. As at the date of this announcement, there are no overlapping directors and senior management between the Company and BACTthe Parent Company or CACL. Moreover, while the Certain executive Directors and the non-executive Directors concurrently serve as director or senior management the general manager and deputy general managers of the Parent CompanyCompany only, and there is no overlapping senior management between the Company and CACL. Moreover, none of the Directors personally has any material interest in the transactions contemplated under the BACT Premises Leasing Agreement entered into by the Company and BACTBusiness Jet Ground Services Joint Operation Agreements. Therefore, none of the Directors has abstained from voting at the Board meeting to approve the BACT Premises Leasing Agreement Business Jet Ground Services Joint Operation Agreements and the transactions contemplated thereunder, including the annual caps. LISTING RULES IMPLICATIONS As at the date of this announcement, the Parent Company is the controlling shareholder of the Company, holding approximately 58.96% of the issued share capital of the CompanyCompany as at the date of this announcement. BACT Since CACL is a wholly-owned subsidiary of the Parent Company and Company, CACL is therefore a connected person of the Company. Accordingly, the BACT Premises Leasing Agreement Business Jet Ground Services Joint Operation Agreements and the transactions contemplated thereunder constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules. As Given that the highest applicable percentage ratio (as defined under Rule 14.07 of the Listing Rules) in respect of the BACT Premises Leasing Agreement Business Jet Ground Services Joint Operation Agreements is more than 0.1% but less than 5%, the BACT Premises Leasing Agreement Business Jet Ground Services Joint Operation Agreements and the transactions contemplated thereunder are subject to the reporting, annual review and announcement requirements, but exempt from the Independent Shareholders’ approval requirement under Chapter 14A of the Listing Rules.

BOARD’S APPROVAL. The BACT BGS Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps, were approved by the Board. As at the date of this announcement, there are no overlapping directors and senior management between the Company and BACTBGS. Moreover, while the executive Directors and the non-executive Directors concurrently serve as director or senior management of the Parent Company, none of the Directors personally has any material interest in the transactions contemplated under the BACT BGS Premises Leasing Agreement entered into by the Company and BACTBGS. Therefore, none of the Directors has abstained from voting at the Board meeting to approve the BACT BGS Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps. LISTING RULES IMPLICATIONS As at the date of this announcement, the Parent Company is the controlling shareholder of the Company, holding approximately 58.96% of the issued share capital of the Company. BACT BGS is a non- wholly-owned subsidiary of the Parent Company. As such, BGS is an associate of the Parent Company and is therefore a connected person of the Company. Accordingly, the BACT BGS Premises Leasing Agreement and the transactions contemplated thereunder constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules. As the highest applicable percentage ratio (as defined under Rule 14.07 of the Listing Rules) in respect of the BACT BGS Premises Leasing Agreement is more than 0.1% but less than 5%, the BACT BGS Premises Leasing Agreement and the transactions contemplated thereunder are subject to the reporting, annual review and announcement requirements, but exempt from the Independent Shareholders’ approval requirement under Chapter 14A of the Listing Rules.

BOARD’S APPROVAL. The BACT BAFM Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps, were approved by the Board. As at the date of this announcement, there are no overlapping directors and senior management between the Company and BACTBAFM. Moreover, while the executive Directors and the non-executive Directors concurrently serve as director or senior management of the Parent Company, none of the Directors personally has any material interest in the transactions contemplated under the BACT BAFM Premises Leasing Agreement entered into by the Company and BACTBAFM. Therefore, none of the Directors has abstained from voting at the Board meeting to approve the BACT BAFM Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps. LISTING RULES IMPLICATIONS As at the date of this announcement, the Parent Company is the controlling shareholder of the Company, holding approximately 58.96% of the issued share capital of the Company. BACT BAFM is a wholly-owned subsidiary of the Parent Company. As such, BAFM is an associate of the Parent Company and is therefore a connected person of the Company. Accordingly, the BACT BAFM Premises Leasing Agreement and the transactions contemplated thereunder constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules. As the highest of the applicable percentage ratio ratios (as defined under Rule 14.07 of the Listing Rules) in respect of the BACT BAFM Premises Leasing Agreement is more than 0.1% but less than 5%, the BACT BAFM Premises Leasing Agreement and the transactions contemplated thereunder are is subject to the reporting, annual review and announcement requirements, but is exempt from the Independent Shareholders’ approval requirement under Chapter 14A of the Listing Rules.

BOARD’S APPROVAL. The BACT CAHM Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps, were approved by the Board. As at the date of this announcement, there are no overlapping directors and senior management between the Company and BACTCAHM. Moreover, while the executive Directors and the non-executive Directors concurrently serve as director or senior management of the Parent Company, none of the Directors personally has any material interest in the transactions contemplated under the BACT CAHM Premises Leasing Agreement entered into by the Company and BACTCAHM. Therefore, none of the Directors has abstained from voting at the Board meeting to approve the BACT CAHM Premises Leasing Agreement and the transactions contemplated thereunder, including the annual caps. LISTING RULES IMPLICATIONS As at the date of this announcement, the Parent Company is the controlling shareholder of the Company, holding approximately 58.96% of the issued share capital of the Company. BACT CAHM is a wholly-owned subsidiary of the Parent Company and is therefore a connected person of the Company. Accordingly, the BACT CAHM Premises Leasing Agreement and the transactions contemplated thereunder constitute continuing connected transactions of the Company under Chapter 14A of the Listing Rules. As the highest applicable percentage ratio (as defined under Rule 14.07 of the Listing Rules) in respect of the BACT CAHM Premises Leasing Agreement is more than 0.1% but less than 5%, the BACT CAHM Premises Leasing Agreement and the transactions contemplated thereunder (including the annual caps) are subject to the reporting, annual review and announcement requirements, but exempt from the Independent Shareholders’ approval requirement under Chapter 14A of the Listing Rules.